Study Stopped
Temporarily paused due to COVID-19 and expected to resume. Resumption timeline unclear due ongoing pandemic. This is not a suspension of IRB approval.
Medical Mindfulness: Virtual Reality Mindfulness Therapy for Anxiety and Pain Management in Patients With Acute and Chronic Pain
VR Mindfulness
1 other identifier
observational
500
1 country
1
Brief Summary
Adults and children undergoing medical care (inpatient or outpatient) often experience pain and anxiety either as a result of their medical condition or a side effect of medical procedures. The purpose of this study is to create a registry of patients using virtual reality (VR) mindfulness therapy through different aspects of their medical care to determine if VR mindfulness therapy is more effective than the standard of care (i.e., no technology based distraction) for treating or preventing anxiety and pain in adults and children suffering from chronic pain, GI conditions where pain is a common symptom, or undergoing any painful medical procedure (i.e. IV access, blood draws, endoscopy, surgery). The anticipated primary outcome will be reduction of pain and anxiety for both acute and chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2018
CompletedFirst Submitted
Initial submission to the registry
August 26, 2020
CompletedFirst Posted
Study publicly available on registry
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2023
CompletedAugust 22, 2022
August 1, 2022
5 years
August 26, 2020
August 18, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
VR Mindfulness Acceptability
Assess the acceptability of a virtual reality mindfulness meditation tool by patients who are experiencing pain, patients diagnosed with gastrointestinal disorders where pain is a common symptom, and by patients undergoing medical procedures.
Up to 1 day (before and after VR use)
Anxiety Outcome
Collect patient report outcome data on anxiety before and after using virtual reality mindfulness meditation.
Up to 1 day (before and after VR use)
Pain Outcome
Collect patient report outcome data on pain levels before and after using virtual reality mindfulness meditation.
Up to 1 day (before and after VR use)
Study Arms (2)
Inpatient Subjects
Inpatients will be presented with an informed consent. If they sign the consent, they will then be given a VR headset pre- programmed with content that they may use for the duration of their stay. GI patients headsets will be collected when they are discharged. There are pain and anxiety analog scales at the end of each program. This data will be downloaded to Stanford. Patient's will not be entering their PHI. we will know who has headsets, as they will be numbered. Patient who are hospitalized for chronic pain will be allowed to take the VR headset home for month and be asked to return it at their followup outpatient visit.
Outpatient Subjects
Outpatient: Patient's who are about to undergo gastrointestinal disease testing or be seen for an outpatient GI appointment will be presented with an informed consent. If they sign the consent, they will be given the VR headset to use prior to their procedure. There are pain and anxiety analog scales at the end of each program. This data will be downloaded to Stanford Medicine Box.Patient's will not be entering their PHI. we will know who has headsets, as they will be numbered.
Interventions
This study is designed to test the feasibility, acceptability and effectiveness of VR mindfulness in patients as they undergo various medical therapies to treat their acute or chronic conditions.
Eligibility Criteria
Males and females age 5-80 of all ethnic backgrounds. We will enroll from GI outpatient clinics (pediatric and adult) as well as any patients who are hospitilized for acute or chronic pain as well as those who are in the preoperative room getting an IV.
You may qualify if:
- Participants must:
- be between ages of 5-80 years of age
- have comprehension of instructions in the English language
- English speaking
- Must be able to comprehend ICF
- Have a medical appointment or procedure at Stanford/LPCH (inpatient or outpatient) that may cause pain or anxiety.
You may not qualify if:
- Significant cognitive impairment/developmental delays
- Seizure Disorder
- history of motion sickness with virtual reality
- severe visual impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University Medical Center
Palo Alto, California, 94305, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda Nguyen, MD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
August 26, 2020
First Posted
September 1, 2020
Study Start
July 10, 2018
Primary Completion
July 10, 2023
Study Completion
July 10, 2023
Last Updated
August 22, 2022
Record last verified: 2022-08